Olivier Elemento
Impact in
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 0.05%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
- Cancer Research 119
- Cancer Genomics and Diagnostics 75
-
- Epigenetics and DNA Methylation 56
- Cancer-related gene regulation 38
- RNA modifications and cancer 29
- Genomics and Chromatin Dynamics 28
- Co-authors
- Samie R. Jaffrey (4 shared papers)Kate D. Meyer (3 shared papers)Christopher E. Mason (10 shared papers)Yogesh Saletore (2 shared papers)Paul Zumbo (3 shared papers)Saeed Tavazoie (12 shared papers)Neel S. Madhukar (13 shared papers)Eugenia G Giannopoulou (13 shared papers)
- Journals
- Blood (36 papers)Nature Communications (32 papers)Cancer Discovery (20 papers)Nature (20 papers)Cell Reports (19 papers)
- Partner nations
- United StatesIsraelItaly
In The Last Decade
Olivier Elemento
510 papers receiving 49.1k citations
Olivier Elemento's Hit Papers
Peers
Comparison fields: 5 of 201
- Cancer Research 11.6k
- Molecular Biology 26.3k
- Oncology 8.8k
- Immunology 5.9k
- Pulmonary and Respiratory Medicine 8.2k
Countries citing papers authored by Olivier Elemento
This map shows the geographic impact of Olivier Elemento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Elemento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Elemento more than expected).
Fields of papers citing papers by Olivier Elemento
This network shows the impact of papers produced by Olivier Elemento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Elemento. The network helps show where Olivier Elemento may publish in the future.
Co-authors
The 25 scholars most cited alongside Olivier Elemento, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 529 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons Hit paper breakdown → | 2012 | 3418 |
| 2 | Integrative Clinical Genomics of Advanced Prostate Cancer Hit paper breakdown → | 2015 | 2985 |
| 3 | 5′ UTR m6A Promotes Cap-Independent Translation Hit paper breakdown → | 2015 | 1528 |
| 4 | Double-stranded DNA in exosomes: a novel biomarker in cancer detection Hit paper breakdown → | 2014 | 1410 |
| 5 | Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer Hit paper breakdown → | 2016 | 1335 |
| 6 | Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer Hit paper breakdown → | 2016 | 1312 |
| 7 | Chromosomal instability drives metastasis through a cytosolic DNA response Hit paper breakdown → | 2018 | 1202 |
| 8 | Punctuated Evolution of Prostate Cancer Genomes Hit paper breakdown → | 2013 | 1004 |
| 9 | Reversible methylation of m6Am in the 5′ cap controls mRNA stability Hit paper breakdown → | 2016 | 885 |
| 10 | The chromatin accessibility landscape of primary human cancers Hit paper breakdown → | 2018 | 802 |
| 11 | Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine Hit paper breakdown → | 2017 | 794 |
| 12 | Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH Hit paper breakdown → | 2015 | 776 |
| 13 | EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation Hit paper breakdown → | 2013 | 689 |
| 14 | Artificial Intelligence in Cancer Research and Precision Medicine Hit paper breakdown → | 2021 | 547 |
| 15 | The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer Hit paper breakdown → | 2014 | 538 |
| 16 | 2013 | 500 | |
| 17 | A molecular single-cell lung atlas of lethal COVID-19 Hit paper breakdown → | 2021 | 476 |
| 18 | Integrative Clinical Genomics of Advanced Prostate Cancer Hit paper breakdown → | 2015 | 461 |
| 19 | 2013 | 456 | |
| 20 | N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer Hit paper breakdown → | 2016 | 443 |
About Olivier Elemento
Olivier Elemento is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Immunology, having authored 529 papers that have together received 49.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (75 papers), Epigenetics and DNA Methylation (56 papers), Lymphoma Diagnosis and Treatment (41 papers), Cancer-related gene regulation (38 papers), RNA modifications and cancer (29 papers), Prostate Cancer Treatment and Research (29 papers), Genomics and Chromatin Dynamics (28 papers) and Immune Cell Function and Interaction (28 papers). The work is most often cited by research in Cancer Research (11.6k citations), Molecular Biology (26.3k citations), Oncology (8.8k citations), Immunology (5.9k citations) and Pulmonary and Respiratory Medicine (8.2k citations). Olivier Elemento has collaborated with scholars based in United States, Israel and Italy. Frequent co-authors include Samie R. Jaffrey, Kate D. Meyer, Christopher E. Mason, Yogesh Saletore, Paul Zumbo, Saeed Tavazoie, Neel S. Madhukar, Eugenia G Giannopoulou, Ari M. Melnick and Deepak P. Patil. Their work appears in journals such as Blood, Nature Communications, Cancer Discovery, Nature and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.